News & Updates

Complications following cataract surgery appear to be more frequent among patients with prior intravitreal injection (IVI) therapy than among those without, as shown in a retrospective study.

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA), compared with metformin, results in a significant decrease in the incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the need for first-line glaucoma treatments in patients with type 2 diabetes (T2D), reports a study.

Two-year treatment with brolucizumab 6 mg every 4 weeks demonstrates noninferiority in mean best-corrected visual acuity (BCVA), with superior anatomic outcomes, to aflibercept 2 mg every 4 weeks in patients with neovascular age-related macular degeneration (nAMD), as shown in the MERLIN study.

Lung function measures are associated with risk of glaucoma, indicating their potential role as biomarkers for the optic neuropathy with a devastating visual impact, researchers from the Chinese University of Hong Kong, Princes of Wales Hospital and Hong Kong Eye Hospital have reported.

The use of semaglutide among individuals with type 2 diabetes (T2D) appears to carry a modest increase in the risk nonarteritic anterior ischemic optic neuropathy (NAION), according to a retrospective study.

In case of failed corneal transplants, performing subsequent endothelial keratoplasty (EK) instead of penetrating keratoplasty (PK) significantly improves long-term regraft survival and visual outcomes, according to a study from Singapore.

A milder enhancement in the orbital optic nerve appears to result in poorer visual acuity (VA) and visual field recovery among eyes with first myelin oligodendrocyte protein (MOG)-related optic neuritis (ON), a study has found.

The presence of xanthelasma palpebrarum (XP), yellow bumps or plaques that appear on eyelids due to cholesterol deposits, does not seem to increase the rates of dyslipidemia or cardiovascular disease (CVD), suggests a study.